Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
Professional society guidelines recommend semiannual screening for hepatocellular carcinoma (HCC) in patients with cirrhosis; however, studies suggest underuse of screening in clinical practice. Our study’s aim was to characterize reasons for HCC screening underuse among patients with cirrhosis. We...
Main Authors: | Patrick Marquardt, Po‐Hong Liu, Joshua Immergluck, Jocelyn Olivares, Ana Arroyo, Nicole E. Rich, Neehar D. Parikh, Adam C. Yopp, Amit G. Singal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1735 |
Similar Items
-
The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma.
by: Neehar D Parikh, et al.
Published: (2016-04-01) -
PRM-MS Quantitative Analysis of Isomeric <i>N</i>-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
by: Cristian D. Gutierrez Reyes, et al.
Published: (2021-08-01) -
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
by: Amit G Singal, et al.
Published: (2014-04-01) -
Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma
by: Chen Hao Jiang, et al.
Published: (2020-01-01) -
Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
by: Michelle R. Ju, et al.
Published: (2020-05-01)